SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs stronger-than-guided quarterly results and upbeat 2027 EBITDA outlook have driven a sharp rally, with traders debating whether short covering could extend the move. Bulls see improving steel operations and prices, while skeptics question whether the outlook can overcome the companys debt and reliance on favorable steel markets; some also warn the rally could fade.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras shares are drawing attention amid a steep selloff, with traders pointing to scheduled lockup expirations and potential insider-share supply, alongside concerns about its IPO valuation, growth and ability to scale. The debate pits bearish calls for further declines against dip-buyers who remain bullish on Cerebras AI-inference technology and long-term demand.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Goldman Sachs Buy upgrade after a sharp selloff is driving attention, but traders are split after the initial pop faded: some see an oversold buying opportunity, while others remain concerned about CoreWeaves heavy debt and financing costs.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is caught in a broad neocloud and AI-infrastructure selloff as traders focus on financing costs, debt concerns and doubts about the sectors business models, with CoreWeaves credit worries adding to contagion fears. The community is split on whether sharp rebounds are durable or bull traps: bulls point to Nebiuss comparatively stronger balance sheet and long-term compute demand, while bears question the capital intensity and path to profitability.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Sea shares are under pressure after a prolonged decline, with traders frequently blaming insider share sales and frustration that management has not announced a fresh buyback. Some see the selloff as a buying opportunity given the companys growth and cash position, while others warn the stock may keep falling and question its valuation and management.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

FDA expanded ANKTIVA plus BCG to cover papillary-only BCG-unresponsive bladder cancer, broadening its potential market; traders also focused on long-term Phase 3 data showing durable responses and bladder-sparing outcomes. Despite bullish views on the commercial opportunity, the shares sold off, with the community debating a sell-the-news reaction and broader biotech weakness versus options-related or short-selling pressure, while some remain cautious about revenue growth and dilution.

X-Energy, Inc. engages in the development of advanced small modular nuclear reactors and fuel technology for clean energy generation. Its solutions include Xe-100 and TRISO-X. The company was founded by Kam Ghaffarian and Eben Mulder in 2009 and is headquartered in Rockville, MD.

X-Energy Inc. - Ordinary Shares- Class A

X-Energy Inc

XEs steep selloff and search for a bottom dominate the discussion, with traders attributing pressure to post-IPO selling, bearish analyst coverage, and weakness across nuclear stocks. Some see Amazons backing and potential SMR demand from data centers as a long-term positive, while others remain concerned that commercialization is years away.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Taus cancer-trial pipeline is driving attention, particularly the FDA-cleared expansion of its recurrent glioblastoma REGAIN study and completed enrollment in the pancreatic IMPACT study ahead of further data updates. Traders are broadly optimistic about these milestones, though expectations for a near-term stock move remain speculative amid price consolidation.

Almonty Industries, Inc. engages in the mining, processing, and shipment of tungsten concentrates. Its projects include Almonty Korea Tungsten, Panasquiera mine, Gentung, Almonty Korea Moly, Los Santos mine, and Valtreixal. The company was founded on September 28, 2009 and is headquartered in Dillon, MT.

Almonty Industries Inc

ALM is drawing attention after a sharp selloff during and following its investor day, with traders criticizing CEO Lewis Blacks presentation and questioning whether it offered meaningful new information. The reaction contrasts with longer-term bullish views on Sangdongs production ramp and tungsten demand, while some attribute weakness to broader market pressure.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta is drawing attention ahead of its Q3 earnings report as shares retreat amid a broader tech and AI selloff. Traders are split over whether strong ad performance and Muse AI momentum can justify heavy AI spending, with capex and returns on that investment central to expectations for the report.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCAPR NewswireNEW YORK, Oct. 15, 2026NEW YORK, Oct. 15, 2026 /PRNewswire/ -- Pomerantz...

Take the Zacks Approach to Beat the Markets: HF Sinclair, Accenture & FirstCash in Focus

HF Sinclair, Accenture and FirstCash post impressive gains as Zacks research portfolios highlight standout performers amid market uncertainty and shifting investor sentiment.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCAPR NewswireNEW YORK, Oct. 8, 2026NEW YORK, Oct. 8, 2026 /PRNewswire/ -- Pomerantz...

HCA Healthcare, Inc. 3rd Quarter 2026 Earnings Conference Call

HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast: What: HCA Healthcare, Inc. 3Q 2026 Earnings Call When: Tuesday, October 27, 2026, at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx...

Can THC's Cash Flow Support Its Expanding Capital-Return Strategy?

Tenet Healthcare's stronger cash flow is fueling bigger buybacks, but growth investments and capital needs will test how sustainable its strategy is.

HCA Healthcare Presents 2026 Awards of Distinction

HCA Healthcare, Inc. (NYSE:HCA), one of the nations leading healthcare providers, today presented its annual HCA Healthcare Awards of Distinction at a ceremony in Nashville, Tennessee. The HCA Healthcare Awards of Distinction, which include the Frist Humanitarian Award and the Excellence in Nursing...

Can Shorter Hospital Stays Help HCA Handle More Patient Demand?

HCA's rising admissions and shorter hospital stays could help it meet growing patient demand while using existing capacity more efficiently.

Can Community Health Sustain Growth as Elective Demand Softens?

CYH's volume growth faces pressure from softer elective procedures and payer mix, while a recovery in demand could help margins and cash flow.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCAPR NewswireNEW YORK, Sept. 24, 2026 NEW YORK, Sept. 24, 2026 /PRNewswire...

Can Tenet Healthcare Sustain Growth Despite Lower Surgical Volumes?

THC's revenue growth persists despite softer surgical volumes, driven by higher revenue per case, acuity and favorable service mix.

HCA Healthcare, Inc. is a health care services company, which engages in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities. The firm operates general and acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services, and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was founded by Dr. Thomas F. Frist, Jr in 1968 and is headquartered in Nashville, TN.

HCA Healthcare Inc

HCA Stock Plummets After Slashing 2026 Guidance – Marks Fifth Straight Day Of Losses

Equity

Bullish Sentiment

<ul class="summary-bullets"><li>HCA lowered its forecasts for net income, adjusted EBITDA, and earnings per share while making only a modest adjustment to its revenue outlook.</li><li>Cantor Fitzgerald said the weaker payer mix likely triggered the stock's sharp decline but maintained its 'Overweight' rating and $525 price target.</li><li>Other healthcare stocks, including Johnson &amp; Johnson, Eli Lilly, Merck, AbbVie, and UnitedHealth Group, also traded lower following HCA's update.</li></ul>HCA Healthcare (HCA) shares fell on Monday morning after the hospital operator cut its 2026 earnings outlook, blaming a worse-than-expected payer mix shift tied to losses in health insurance coverage.&nbsp;The company also raised the size of the headwind from health insurance exchanges, a sign that coverage changes are pressuring reimbursement more than it had previously modeled.<a href="https://stocktwits.com/symbol/HCA/">HCA stock</a> fell nearly 7% in morning trade to under $365, recovering from earlier lows seen in August last year and extending its losing streak. On Stocktwits, retail sentiment around the stock remained in ‘neutral’ territory with chatter at ‘normal’ levels.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/HCA_2026_07_14_11_09_25_png_9c4cdbe62d.webp" alt="HCA_2026-07-14_11-09-25.png" width="1772" height="948"><figcaption>HCA stock performance since August 2026. | Source: TradingView</figcaption></figure>Some retailers on the platform expressed interest in buying the stock amid the downturn.<stembedurl>https://www.stocktwits.com/IAMCapital1/message/658966742</stembedurl><stembedurl>https://www.stocktwits.com/Only4TheShow/message/658985941</stembedurl><h2 class="st-heading-2">Guidance Cut, But Revenue Range Mostly Intact</h2>HCA lowered several key 2026 profit targets while leaving its revenue outlook only slightly narrower. The company now sees revenue of $77 billion to $79.5 billion, down from a prior range of $76.5 billion to $80 billion, while net income attributable to HCA is now expected to come in between $6.3 billion and $6.7 billion, versus an earlier range of $6.495 billion to $7.035 billion."Our colleagues continue to manage well through the positive and negative factors that have impacted our business in the first half of the year,” said Sam Hazen, Chief Executive Officer of HCA Healthcare. "As we look to the balance of the year, we have adjusted our guidance to reflect these factors."&nbsp;Adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) guidance was also trimmed to $15.4 billion to $16.1 billion from $15.55 billion to $16.45 billion. Earnings per diluted share were cut to a range of $28.70 to $30.50, compared with the prior forecast of $29.10 to $31.50.&nbsp;<h2 class="st-heading-2">Health Insurance Exchange Headwinds Grow</h2>The company kept its 2026 capital spending plan unchanged at $5 billion to $5.5 billion, excluding acquisitions, suggesting it is not pulling back on longer-term investment even as profit expectations soften.HCA said the cuts were driven by the expectation of a larger unfavorable impact from health insurance exchanges. It stated that the drag on income before taxes would widen to between $1 billion and $1.2 billion from an earlier estimate of $600 million to $900 million. That points to a less favorable payer mix, meaning a larger share of patients are arriving with coverage that reimburses less richly than the company had anticipated.<h2 class="st-heading-2">Analysts Point To Payer Mix Concerns</h2>In a note to investors cited by TheFly, Cantor Fitzgerald said the guidance, due to worsening payor mix, is the likely trigger for the sharp stock sell-off. It added that the downturn is weighing on healthcare peers as results fell short of expectations. The firm has an ‘Overweight’ rating on HCA’s stock and a $525 price target.Shares of Johnson and Johnson (JNJ), expected to report earnings later this week, fell by nearly 2%. Shares of Eli Lilly (LLY) and Merck (MRK) dropped nearly 3% each, while AbbVie (ABBV) and UnitedHealth Group (UNH) moved over 1% lower.&nbsp;Earlier in the day, KeyBanc also lowered its price target on HCA Healthcare to $475 from $510 and kept an ‘Overweight’ rating on the shares, citing “uncertainty” around hospitals' core earnings trajectory.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/ibm-stock-tanks-to-2-month-lows-in-pre-market-ceo-says-company-faltered/cZZbDWbR7ps">IBM Stock Tanks To 2-Month Lows In Pre-Market – CEO Says Company ‘Faltered’ In Q2 As ‘Large Deals Failed To Close’ On Expected Timelines</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

In this photo illustration, HCA Healthcare’s logo is on a smartphone with an economic stock exchange index graph in the background. (Photo Illustration by Budrul Chukrut/SOPA Images/LightRocket via Getty Images) 

HCA Healthcare (HCA) shares fell on Monday morning after the hospital operator cut its 2026 earnings outlook, blaming a worse-than-expected payer mix shift tied to losses in health insurance coverage. 

Why Is HCA Stock Falling Today?

The company attributed the guidance cut to a larger-than-expected shift in payer mix and a greater financial impact from health insurance exchanges.


Johnson & Johnson

Lilly(Eli) & Co

Merck & Co Inc

Unitedhealth Group Inc

Health Care Select Sector SPDR Fund

Track HCA stock price, charts, news and real-time market activity on Stocktwits. Join the HCA message board to follow investor discussions, retail trader sentiment, bullish and bearish signals around HCA Healthcare Inc stock.

HCA Stock Price Today - HCA Healthcare Inc News, Charts, Retail Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$457.07
Prev Close	$458.84
Open	$456.76
Dividend Yield	0.62%
50-Day Moving Average	$426.49
Beta	0.33
Avg. Volume	1.52M
PE Ratio	15.36

52-Week High	$556.52
52-Week Low	$353.99
Market Capitalization	$99.34B
EPS (Annual)	$28.33
Price to Book	-15.06
Revenue Per Employee	$236,250.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

HCA Fundamentals